Moreover, peroxisome proliferator-activated receptors-gamma (PPAR-γ) ligands, in addition to their role in diabetes and adipogenesis, are shown to inhibit tumor growth and progression in preclinical models of cancer, by modulating various cellular processes in cancer cells, stromal cells, and tumor microenvironment [7]. This evidence concerns the gene PPARG and cancer.